Europe Tumor Ablation Market Size & Outlook, 2023-2030

The tumor ablation market in Europe is expected to reach a projected revenue of US$ 900.6 million by 2030. A compound annual growth rate of 12.8% is expected of Europe tumor ablation market from 2024 to 2030.
Revenue, 2023 (US$M)
$388.2
Forecast, 2030 (US$M)
$900.6
CAGR, 2024 - 2030
12.8%
Report Coverage
Europe

Europe tumor ablation market, 2018-2030 (US$M)

Europe

Europe tumor ablation market highlights

  • The Europe tumor ablation market generated a revenue of USD 388.2 million in 2023.
  • The market is expected to grow at a CAGR of 12.8% from 2024 to 2030.
  • In terms of segment, radiofrequency ablation was the largest revenue generating technology in 2023.
  • Other Ablation Technologies is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, Russia is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 388.2 million
Market revenue in 2030USD 900.6 million
Growth rate12.8% (CAGR from 2023 to 2030)
Largest segmentRadiofrequency ablation
Fastest growing segmentOther Ablation Technologies
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationRadiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies
Key market players worldwideMedtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service


Other key industry trends

  • In terms of revenue, Europe region accounted for 23.2% of the global tumor ablation market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,085.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Tumor Ablation Market Scope

Tumor ablation market segmentation & scope
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation
Other Ablation Technologies
Surgical Ablation
Laparescopic Ablation
Percutaneous Ablation
Kidney Cancer
Liver Cancer
Breast cancer
Lung Cancer
Prostate Cancer
Other Cancer

Tumor Ablation Market Companies

Name Profile # Employees HQ Website

Europe tumor ablation market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.


Radiofrequency ablation was the largest segment with a revenue share of 34.54% in 2023. Horizon Databook has segmented the Europe tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.


Europe accounted for a significant share of the tumor ablation market. Growing initiatives & awareness campaigns on early disease diagnosis and its treatment, greater extent of public funding in Europe’s healthcare system, increasing incidence of cancers, and rising life expectancy have contributed to market growth.

According to WHO, Europe accounts for nearly a quarter of total cancer cases worldwide, with 3.7 million new patients every year. Among all types of cancers, stomach, lung, liver, breast, and colon cancers have caused the highest number of deaths every year.

Furthermore, benefits associated with minimally invasive tumor ablation procedures, such as lower risk, less cost of procedure & shorter recovery duration, high adoption of advanced technologies, increasing reimbursement for surgical procedures, and growing demand for minimally invasive procedures over traditional methods, are expected to drive the market during the forecast period.

Reasons to subscribe to Europe tumor ablation market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe tumor ablation market databook

  • Our clientele includes a mix of tumor ablation market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe tumor ablation market , including forecasts for subscribers. This continent databook contains high-level insights into Europe tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe tumor ablation market size, by country, 2018-2030 (US$M)

Europe Tumor Ablation Market Outlook Share, 2023 & 2030 (US$M)

Europe tumor ablation market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more